Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-11

Clinical Trial Update: Efficacy of Levetiracetam in Oromandibular and Cranial Dystonia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated the efficacy of levetiracetam in treating oromandibular dystonia and cranial dystonia; results were posted in 2017 after stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Oromandibular Dystonia, Cranial Dystonia | Phase 2 | Status: COMPLETED | Results posted: 2017-07-11